UF Innovate Honors Innovators at Fifth Standing InnOvation Celebration
More than 200 innovators and entrepreneurs gathered for UF Innovate | Tech Licensing’s fifth annual Standing InnOvation event to honor and celebrate innovators and their work at the University of Florida in fiscal year 2022.
QRDI’s Qatar Open Innovation Program Announces Winning Partnerships
The Qatar Research, Development and Innovation (QRDI) Council’s flagship program, Qatar Open Innovation (QOI), has announced the two winning innovation partnerships for Hassad Food, Qatar’s investment arm in food and agribusiness sectors, one of which is a UF startup and Accelerate resident, Micro Nano Technologies.
UF Innovate Hosts First Fast Break Ventures Summit
Investors, innovators, and entrepreneurs convened at the University of Florida Stephen C. O’Connell Center for UF Innovate | Ventures' first-annual Fast Break Ventures Summit. Over 100 attendees met on center court for an afternoon filled with discussion on the state of venture capital in Florida and to hear pitches from six startup companies.
Orange County Hands Out Thousands of Free Mosquito Traps
Last month, Orange County Mosquito Control identified approximately 93,000 acres that are seeing more mosquitoes. Because of that influx, the county and the University of Florida’s Institute of Food and Agricultural Sciences are handing out free mosquito traps.
The traps were invented in a UF lab. And the company that now sells them, Inzecto Mosquito Trap, donated 100,000 traps to hard-hit communities impacted by hurricane Ian. 9,000 of those traps went to Orange County.
UF Start-Up Helps Fight Mosquitoes in Areas Hit Hardest by Hurricane Ian
A product developed in a University of Florida lab designed to protect American soldiers from insect-borne diseases is helping wage war against the surge of mosquitoes in areas hardest hit by Hurricane Ian.
The Inzecto Mosquito Trap, co-created by Phil Koehler, a UF distinguished professor in the department of entomology and nematology, is an easy-to-use, environmentally friendly, and effective mosquito-killing device. The Gainesville-based company donated 100,000 traps this week to communities struggling with large populations of mosquitoes due to the floodwaters left behind by the hurricane’s rain and storm surges.
Dr. Barry Byrne Named Innovator of the Year
The annual event honored Dr. Barry Byrne as Innovator of the Year for his contributions to gene therapy and highlighted six teams of inventors for their Inventions of the Year.
Novel Target Discovered for Potentially Treating and Preventing Osteoarthritis
Scientists at UF Scripps Biomedical Research have described a specific protein that manages activities within chondrocytes, a critical cell type that maintains healthy cartilage in joints. As people age and stress their joints, their chondrocytes begin to fail. The UF Scripps team found that activating a specific protein in these cells called RORβ (beta) could restore multiple factors needed for smooth joints to healthier levels, helping to control inflammation.
Wertheim Foundation provides lead gift of $100 million to UF Scripps
The University of Florida today announced that the Dr. Herbert and Nicole Wertheim Family Foundation has provided $100 million — the largest gift from an individual donor in university history — to elevate the stature of UF Scripps as one of the world’s leading forces in biomedical research and to advance the leading-edge work of faculty at the campus in Jupiter, Florida.
Here’s How AI Could Bring Better Fruit to Your Table
Researchers at the University of Florida envision a quicker method: exploring the natural variations in plant genetics using artificial intelligence. The applications extend far beyond blueberries, a growing sector of Florida’s $182.6 billion agriculture industry. Their brainchild, the AI Connoisseur, would not only give Florida farms an edge, but make healthy food more palatable to more people, bringing varieties with heirloom-quality flavor within everyone’s reach. All they’d have to do is teach a computer to taste.
TearClear Announces Positive Topline Results From Clear Phase 3 Study for the Treatment of Glaucoma
TearClear, an ophthalmic pharmaceutical company that transforms trusted drugs into branded best-in-class therapies, announced that the company’s will file a NDA with the FDA on their lead product. This product will offer patients the first and only means of delivering preservative-free doses of latanoprost from conventional multi-dose bottles.
